at-home research study for patients with autoimmune, inflammatory, genetic, hematological, infectious, neurological, cns, oncological, respiratory, metabolic conditions

Conditions: All Diagnosed Health Conditions; ADD/ADHD; Alopecia Areata; Ankylosing Spondylitis; Asthma; Atopic Dermatitis Eczema; Beta Thalassemia; Bipolar Disorder; Breast Cancer; Celiac Disease; Cervical Cancer; Chronic Inflammatory Demyelinating Polyneuropathy; Chronic Kidney Diseases; Chronic Obstructive Pulmonary Disease; Colon Cancer; Colorectal Cancer; Crohn's Disease; Cystic Fibrosis; Depression; Diabetes Mellitus; Duchenne Muscular Dystrophy; Endometriosis; Epilepsy; Facioscapulohumeral Muscular Dystrophy; G6PD Deficiency; General Anxiety Disorder; Hepatitis B; Hereditary Hemorrhagic Telangiectasia; HIV/AIDS; Human Papilloma Virus; Huntington's Disease; Idiopathic Thrombocytopenic Purpura; Insomnia; Kidney Cancer; Leukemia; Lung Cancer; Lupus Nephritis; Lymphoma; Melanoma; Multiple Myeloma; Multiple Sclerosis; Myositis; Myotonic Dystrophy; Ovarian Cancer; Pancreatic Cancer; Parkinson's Disease; Polycystic Kidney Diseases; Prostate Cancer; Psoriasis; Psoriatic Arthritis; Rosacea; Scleroderma; Sickle Cell Anemia; Sickle Cell Trait; Sjogren's Syndrome; Skin Cancer; Spinal Muscular Atrophy; Systemic Lupus Erythematosus; Thrombotic Thrombocytopenic Purpura; Trisomy 21; Ulcerative Colitis

Summary: we are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. we make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

this study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Eligibility criteria:
inclusion criteria: * all adults 18-100 years old * able to provide proof of diagnosis * live in usa exclusion criteria: * younger than 18 years old * receipt of blood products within 30 days of study blood collection * receipt of investigational drug within 30 days of study blood collection

Keywords: add/adhd alopecia areata ankylosing spondylitis asthma atopic dermatitis eczema beta thalassemia bipolar disorder breast cancer celiac disease cervical cancer chronic inflammatory demyelinating polyneuropathy chronic kidney diseases chronic obstructive pulmonary disease colon cancer colorectal cancer crohn's disease cystic fibrosis depression diabete mellitus duchenne muscular dystrophy endometriosis epilepsy facioscapulohumeral muscular dystrophy g6pd deficiency general anxiety disorder hepatitis b hereditary hemorrhagic telangiectasia hiv/aids human papilloma virus huntington's disease idiopathic thrombocytopenic purpura insomnia kidney cancer leukemia lung cancer lupus nephritis lymphoma melanoma multiple myeloma multiple sclerosis myositis myotonic dystrophy ovarian cancer pancreatic cancer parkinson's disease polycystic kidney diseases prostate cancer psoriasis psoriatic arthritis rosacea scleroderma sickle cell anemia sickle cell disease sickle cell trait sjogren's syndrome skin cancer spinal muscular atrophy systemic lupus erythematosus thrombotic thrombocytopenic purpura trisomy 21 ulcerative colitis